China

3 Big Pharma Stocks Racing Along the Road to China
3 Big Pharma Stocks Racing Along the Road to China
Motley Fool
China
cancer
Pfizer
AstraZeneca
JNJ
Flag link:
Novartis signs manufacturing deal for Kymriah in China
Novartis signs manufacturing deal for Kymriah in China
BioCentury
Novartis
Kymriah
China
drug manufacturing
Flag link:
Chinese pharma market primed for growth after sweeping reforms
Chinese pharma market primed for growth after sweeping reforms
Pharmaforum
China
Flag link:
As China builds biotech sector, cash floods U.S. startups
As China builds biotech sector, cash floods U.S. startups
Yahoo/Reuters
China
biotech
startups
Flag link:
Allergan, eyeing Asia for growth, pours $14.7M into first medical aesthetics center in China
Allergan, eyeing Asia for growth, pours $14.7M into first medical aesthetics center in China
Fierce Pharma
China
Allergan
Flag link:
AZ expands role in China, to include robots and health tech
AZ expands role in China, to include robots and health tech
Pharmaforum
AstraZeneca
China
robotics
digital health
artificial intelligence
Flag link:
Merck follows Opdivo’s suit, prices Keytruda in China at half its U.S. tag
Merck follows Opdivo’s suit, prices Keytruda in China at half its U.S. tag
Fierce Pharma
drug pricing
China
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
Flag link:
Novo Nordisk to Lay off 400 to Focus on Innovation
Novo Nordisk to Lay off 400 to Focus on Innovation
BioSpace
Novo Nordisk
R&D
layoffs
Denmark
China
Flag link:
Chinese scientist pleads guilty in plot to steal GSK secrets
Chinese scientist pleads guilty in plot to steal GSK secrets
Business Insider
China
trade secrets
GSK
Flag link:
R&D Cooperation Between China and Western Pharma Companies Up 70 Percent
R&D Cooperation Between China and Western Pharma Companies Up 70 Percent
BioSpace
China
R&D
Flag link:
Eisai and Merck Announce China Approval of Lenvima for Treatment of Unresectable Hepatocellular Carcinoma
Eisai and Merck Announce China Approval of Lenvima for Treatment of Unresectable Hepatocellular Carcinoma
CP Wire
China
Eisai
Merck
Lenvima
liver cancer
HCC
Flag link:
Boost for "made in China" medicine as Chi-Med wins key approval
Boost for "made in China" medicine as Chi-Med wins key approval
Yahoo/Reuters
China
Chi-Med
Eli Lilly
fruquintinib
colorectal cancer
Flag link:
Researcher admits plot to steal GSK secrets to sell in China
Researcher admits plot to steal GSK secrets to sell in China
Washington Times
GSK
China
trade secrets
Flag link:
Major Expected Events from AstraZeneca’s R&D in H2 2018
Major Expected Events from AstraZeneca’s R&D in H2 2018
Market Realist
AstraZeneca
China
Lynparza
Tagrisso
Imfinzi
Flag link:
Bristol-Myers will sell Opdivo in China at half of US cost, setting precedent for checkpoint wave — report
Bristol-Myers will sell Opdivo in China at half of US cost, setting precedent for checkpoint wave — report
Endpoints
Bristol-Myers Squibb
China
Opdivo
drug pricing
Flag link:
Gilead loses key patent claims for Sovaldi in China, opening door to earlier generic entry
Gilead loses key patent claims for Sovaldi in China, opening door to earlier generic entry
Endpoints
China
Gilead Sciences
hepatitis C
generics
Sovaldi
Flag link:
The Chinese pharmaceutical market keeps growing and offering opportunities to large industrial groups
The Chinese pharmaceutical market keeps growing and offering opportunities to large industrial groups
GoinPharma
China
Flag link:
Touting its manufacturing strengths, Tot Biopharm raises $102M mega-round to ramp up cancer R&D
Touting its manufacturing strengths, Tot Biopharm raises $102M mega-round to ramp up cancer R&D
Endpoints
China
oncology
Tot Biopharm
Flag link:
China Approves Gilead's Genvoya for HIV-1 Infection
China Approves Gilead's Genvoya for HIV-1 Infection
CP Wire
Gilead Sciences
China
Genvoya
HIV
Flag link:
Novartis licenses out unwanted GlaxoSmithKline cancer drugs to Chinese biotech
Novartis licenses out unwanted GlaxoSmithKline cancer drugs to Chinese biotech
Fierce Biotech
Novartis
China
Laekna
cancer
afuresertib
uprosertib
Flag link:

Pages